Erythropoietin Protein (Human EPO)

<strong>Human Erythropoietin Protein (EPO)</strong>_x000D_ <table width="463">_x000D_ <tbody>_x000D_ <tr>_x000D_ <td>Catalog number:</td>_x000D_ <td>P2010011</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Lot number:</td>_x000D_ <td>Batch Dependent</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Expiration date:</td>_x000D_ <td>Batch Dependent</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Package Size:</td>_x000D_ <td>25 ug</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Synonyms:</td>_x000D_ <td>MVCD2 protein, EPO protein, EP protein</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Source:</td>_x000D_ <td>Recombinant (insect cells)</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Molecular Weight:</td>_x000D_ <td>20 kDa</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Concentration:</td>_x000D_ <td>250 µg/mL</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Buffer:</td>_x000D_ <td>PBS + 10% Glycerol</td>_x000D_ </tr>_x000D_ <tr>_x000D_ <td>Storage:</td>_x000D_ <td>-20¬∞C or lower. Avoid repeated freeze-thaw.</td>_x000D_ </tr>_x000D_ </tbody>_x000D_ </table>_x000D_ &nbsp;_x000D_ _x000D_ <strong>References</strong>_x000D_ <ul>_x000D_ <li>Erythropoietin Does Not Alter Serum Profiles of Neuronal and Axonal Biomarkers After Traumatic Brain Injury: Findings From the Australian EPO-TBI Clinical Trial. ¬†<span class="labs-docsum-authors full-authors">Hellewell SC, Mondello S, Conquest A, Shaw G, Madorsky I, Deng JV, Little L, Kobeissy F, Bye N, Bellomo R, Cooper DJ, Vallance S, Board J, Morganti-Kossmann MC.</span> <span class="labs-docsum-journal-citation full-journal-citation">Crit Care Med. 2018 Apr;46(4):554-561.</span></li>_x000D_ <li>Roxadustat (FG-4592) Versus EpoetinAlfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study.<span class="labs-docsum-authors full-authors"> Provenzano R, Besarab A, Wright S, Dua S, Zeig S, Nguyen P, Poole L, Saikali KG, Saha G, Hemmerich S, Szczech L, Yu KH, Neff TB.</span> <span class="labs-docsum-journal-citation full-journal-citation">Am J Kidney Dis. 2016 Jun;67(6):912-24.</span></li>_x000D_ <li>A phase 3 randomized, placebo-controlled study assessing the efficacy and safety of epoetin-Œ± in anemic patients with low-risk MDS.<span class="labs-docsum-authors full-authors"> Fenaux P, Santini V, Spiriti MAA, Giagounidis A, Schlag R, Radinoff A, Gercheva-Kyuchukova L, Anagnostopoulos A, Oliva EN, Symeonidis A, Berger MH, G√∂tze KS, Potamianou A, Haralampiev H, Wapenaar R, Milionis I, Platzbecker U.</span> <span class="labs-docsum-journal-citation full-journal-citation">Leukemia. 2018 Dec;32(12):2648-2658.</span></li>_x000D_ <li>Structure-Function Relationships for Recombinant Erythropoietins: A Case Study From a Proposed Manufacturing Change With Implications for Erythropoietin Biosimilar Study Designs.<span class="labs-docsum-authors full-authors"> Grampp G, McElroy PL, Camblin G, Pollock A.</span> <span class="labs-docsum-journal-citation full-journal-citation">J Pharm Sci. 2018 Jun;107(6):1512-1520.</span></li>_x000D_ <li>Comparing Therapeutic Efficacy and Safety of Epoetin Beta and Epoetin Alfa in the Treatment of Anemia in End-Stage Renal Disease Hemodialysis Patients.<span class="labs-docsum-authors full-authors"> Azmandian J, Abbasi MR, Pourfarziani V, Nasiri AA, Ossareh S, Ezzatzadegan Jahromi S, Sanadgol H, Amini S, Shahvaroughi Farahani A.</span> <span class="labs-docsum-journal-citation full-journal-citation"><a href="https://pubmed.ncbi.nlm.nih.gov/30253403/">Am J Nephrol</a>. 2018;48(4):251-259. </span></li>_x000D_ </ul>